Sponsor content
322 result(s) found, displaying 211 to 220
-
Australian public assessment report (AusPar)Australian Public Assessment for Benralizumab
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TAGRISSO osimertinib 40 mg (as osimertinib mesilate) tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TAGRISSO osimertinib 80 mg (as osimertinib mesilate) tablet blister pack.
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Australian public assessment report (AusPar)Australian Public Assessment for Olaparib
-
-
Prescription medicine registrationActive ingredients: durvalumab (rch).
-
-
Prescription medicine registrationActive ingredients: glycopyrronium bromide (glycopyrrolate); formoterol (eformoterol) fumarate dihydrate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SYNAGIS palivizumab (rmc) 100 mg / 1 mL solution for injection vial.